JP Morgan Private Wealth Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$314K	Buy	+2,151	New	+$405K	﹤0.01%	1454
2015 Q3	–	Sell	-831	Closed	-$65K	–	1105
2015 Q2	$65K	Buy	831 +402	+94%	+$33.7K	﹤0.01%	1028
2015 Q1	$29K	Hold	429	–	–	﹤0.01%	1121
2014 Q4	$40K	Hold	429	–	–	﹤0.01%	1075
2014 Q3	$45K	Hold	429	–	–	﹤0.01%	1062
2014 Q2	$61K	Hold	429	–	–	﹤0.01%	874
2014 Q1	$65K	Buy	+429	New	+$84.5K	﹤0.01%	859

Other funds holding MDGL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Private Wealth Advisors's MDGL Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2023: 2,151 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #1454 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in MDGL as recently as Q2 2015.

JP Morgan Private Wealth Advisors first reported a position in MDGL in Q1 2014 and has held it in 7 quarters since. 205 funds tracked by Wall St. Rank hold MDGL as of Q3 2023.

JP Morgan Private Wealth Advisors held 2,151 shares of Madrigal Pharmaceuticals worth $314K as of Q3 2023.
Madrigal Pharmaceuticals was a new JP Morgan Private Wealth Advisors position in Q3 2023.
Madrigal Pharmaceuticals made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1454 holding.
JP Morgan Private Wealth Advisors first reported a position in Madrigal Pharmaceuticals in Q1 2014 and has held it in 7 quarters since.
205 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.